Terms: = Germ cell tumor AND ACKR3 AND Prognosis
1 results:
1. A Chimeric Antibody against ackr3/CXCR7 in Combination with TMZ Activates Immune Responses and Extends Survival in Mouse GBM Models.
Salazar N; Carlson JC; Huang K; Zheng Y; Oderup C; Gross J; Jang AD; Burke TM; Lewén S; Scholz A; Huang S; Nease L; Kosek J; Mittelbronn M; Butcher EC; Tu H; Zabel BA
Mol Ther; 2018 May; 26(5):1354-1365. PubMed ID: 29606504
[TBL] [Abstract] [Full Text] [Related]
